but you need to get regular blood tests to monitor its blood-thinning effects and make sure you are on the right dose. You don’t need to do that if you’re on a DOAC.
Methods In a multicenter, double-blind, randomized trial, we compared fixed-dose subcutaneous low-molecular-weight heparin (tinzaparin sodium) given once daily with dose-adjusted intravenous heparin given by continuous infusion using objective documentation of clinical outcomes. Pulmonary embolism at study...
The characteristics of the 30 consecutive included patients receiving tinzaparin at treatment dose (six men, 24 women) were: age 87 0 +/- 5.9 years (range: 71-96 years), body weight: 62. 7 +/- 14. 6 kg (range: 38-90 kg) and creatinine clearance 40. 6;+/- 15.3 mL/ min (...
For more precise, weight-adjusted dosing of the t-PA variant, see also Gibson et al., Am. J. Cardiol. 84:976-980 (1999). Weight adjusted dose typically varies between about 0.2 mg/kg of body weight and about 1.25 mg/kg of body weight. [0079] Low molecular weight heparin, such ...
Dosing of canakinumab is 600 mg in 250 mL of 5% dextrose intravenously over 2 h for patients weighing 40–60 kg (not exceeding 10 mg/kg) [17]. 6.5. Anakinra Anakinra is an interleukin antagonist. In an Italian cohort study, the use of a high dose of anakinra on patients with COVID-...